Home
Features
-
The CDMO/CMO and Suppliers Report: Biomanufacturing
Driven by increased demand in biologic-based drugs, biomanufacturing (biologic drug substance) continues to be an active area of investment by CDMOs/CMOs, including several multi-billion large-scale biomanufacturing projects. What companies are expanding and where do these expansions stand?
-
Drug Shortages on the Rise; US Gov’t Proposes New Actions to Address
The number of drug shortages in the US has reached a new all-time high, with more than 320 drugs in shortage, according to an analysis by a pharmacist trade group. Earlier this month, the White House proposed new actions to address the problem, including additional requirements for manufacturers.
DCAT MEMBER COMPANY COMMUNITY
-
New Member Company Alert
Welcome to our Newest Member Companies! We are pleased to welcome the following companies to our DCAT Member Community. From the March 1, 2024 issue of DCAT Value Chain Insights: From…
-
People on the Move
Here are the latest moves and promotions of employees from the DCAT Member Company community. To submit a request to be included in People on the Move, click here. From the…
-
Women Leaders in Pharma Interview: Laura Zurlinden, Vice President of Business Development, Clinical Services in North America, PCI Pharma Services
The latest interview in the DCAT Alliance for Industry Women Committee’s Women Leaders in Pharma: An Interview Series features Laura Zurlinden, Vice President of Business Development, Clinical Services in North America, PCI Pharma Services.…
-
People on the Move
Here are the latest moves and promotions of employees from the DCAT Member Company community. To submit a request to be included in People on the Move, click here. From the…